Emcure is 12th Largest Indian Pharmaceuticals Company (according to AWACS). It has more than 10000 employees working across globe with operating profit of $220million and a global turnover of more than 5000cr. Established presence in all major therapeutic areas including gynaecology, nephrology, blood related, cardiology, pain & analgesics, HIV, anti-infective, and vitamins, minerals and nutrients products. Emcure has also recently entered the oncology and diabetes therapeutic areas.
Emcure has over 800 products which are currently being marketed across 70+ countries, with subsidiaries spread across Dubai, Brazil, South Africa, Singapore and Nigeria; Branch offices in Russia, Myanmar, Ghana and Morocco; and Established offices in US, UK and Canada. Emcure is working towards vast expansion in European Markets as well.